5.7.5. surgical treatment underactive bladder. surgical options male patients non-neurogenic uab/du include benign prostatic surgery sacral neuromodulation [165,780-786]. 5.7.5.1. surgery benign prostatic obstruction sr evaluated outcomes surgery benign prostatic obstruction men pre-operative du acontractile detrusor . mean total ipss variation following surgery reported range -3 -19.5 points. >3 points improvement terms total ipss score evident fourteen studies included sr . mean ipss qol score variation ranged -0.9 -3 points . mean maximum urinary flow (qmax) improvement ranged +1.4 +11.7 ml/s. mean pvr improvement ranged -16.5 -736 ml . direct comparisons patients du versus without du provided conflicting results . study found post-operative outcomes one month photoselective laser vaporisation prostatectomy (pvp) worse patients du compared patients without du . men pre-operative du, mean total ipss score improved 12.0 15.2, mean qmax improved 4.8 ml/sec 8.2 ml/sec, mean pvr improved 918.3 ml 325.9 ml. patients without pre-operative du mean total ipss improved 17.5 9.7, mean qmax improved 6.9 ml/sec 17.6 ml/sec, mean pvr improved 225.0 ml 99.2 ml . statistically significant difference (p ≤ 0.05) observed terms mean ipss, mean qmax, mean pvr comparing patients without pre-operative du one month follow-up . similarly, another study found patients du smaller decrease terms median total ipss (-6.5 vs. -11) smaller increase qmax (+3.5 ml/s vs. +8.2 ml/s) pvp without du . details, men du median total ipss score improved 17.5 9.5, median qmax improved 9.7 ml/sec 13.8 ml/sec median pvr improved 28 ml 11.5 ml. patients without pre-operative du median ipss improved 20.5 8, median qmax improved 10 ml/sec 17.9 ml/sec, median pvr improved 27.5 ml 9 ml . statistical analysis found significant differences two groups follow-up evaluations terms qmax (p: 0.023). authors failed find differences terms symptom improvement success rates patients without pre-operative du . mean bladder contractility index (bci) improvement reported range 4 44.6 . retrospective study found 81.7% patients du acontractile detrusor undergoing turp tuip achieved satisfactory treatment outcome defined improved qol voiding efficiency >50% . among patients, mean bci significantly increased 16.4 61.0 69.4% recovery detrusor function within 3 months . prospective case series found 78% patients du acontractile detrusor concurrent bpo undergoing holmium laser enucleation prostate exhibited significant return bladder contractility, determined presence sustained, volitional detrusor contraction six months follow-up . note, 94.7% patients voiding spontaneously acceptable pvr volume, whereas 5.3% required cic post-operatively . factors influencing surgical outcomes investigated: older age, lack obstruction, concomitant detrusor overactivity, lower detrusor contractility use transurethral resection prostate photovaporisation instead holmium laser enucleation prostate (holep) associated worse outcomes . retrospectively investigated effect du efficacy turp comparing subjective objective parameters preoperatively three months post-operatively severe (bci < 82), mild (82 ≤ bci < 100), absent du (bci ≥ 100) two obstruction groups (20 ≤ bladder outlet obstruction index (booi) < 40 booi ≥ 40) . successful improvement operation defined according criteria developed homma et al. . patients pre-operative booi ≥ 40 successful improvement rates ipss, ipss-storage, ipss-voiding, qol free qmax 60.6%, 54.5%, 54.5%, 63.6% 66.6% patients severe du. figures patients booi ≥ 40 mild du were: 87.7%, 63.2%, 94.7%, 75.4%, 75.4%, respectively. finally, patients booi ≥ 40 absent du successful improvement rates 94.1%, 82.8%, 95.6%, 90.6%, 71.4%, respectively. 20 ≤ booi < 40 group, successful improvement rates ipss, ipss-storage, ipss-voiding, qol free qmax severe du patients 38.2%, 38.2%, 44.1%, 41.2% 38.2%, respectively. figures patients mild du were: 83.3%, 66.7%, 83.3%, 75.0%, 41.7%, respectively. finally, patients absent du successful improvement rates 90.9%, 90.9%, 90.9%, 90.9%, 81.8%, respectively. therefore, patients varying degrees benign prostate obstruction benefit turp, patients severe du 20 ≤ booi < 40 group, turp carefully considered adequate counselling . unfortunately, long-term data available seem reveal poor durability benefits . 5.7.5.2. sacral neuromodulation sacral neuromodulation (snm) reported improve idiopathic urinary retention women long-term studies . however, scarce evidence exists men du acontractile detrusor. multicentric, retrospective case series reported outcomes sns adults urodynamic‐based diagnosis du symptom duration six months failed respond first second‐line treatment options . patients cognitive disabilities, boo contraindication sns excluded. overall, 35 males included. these, 51.4% responded first stage candidates full implant. overall, 72% male patients favourable responses full implantation. voided volume, pvr, median qmax improved sexes . men underwent full implantation voided volume improved 75.0 ml 300.0 ml, pvr improved 350.0 ml 90.0 ml, mean qmax improved 7.0 ml/sec 16.0 ml/sec. evidence another retrospective study suggests residual detrusor contractility likely respond trial snm compared detrusor acontractility . summary evidencelein patients du acontractile detrusor concomitant benign prostatic obstruction, de-obstruction procedures associated improvements bladder contractility index, mean total international prostate symptom score, mean maximum urinary flow, mean postvoid residual volume.3older age, lack bladder outflow obstruction, concomitant detrusor overactivity, lower bladder contractility use transurethral resection prostate photo vaporisation instead laser enucleation prostate associated worse post-operative outcomes de-obstruction procedures.3sacral neuromodulation provides statistically significant improvement terms voided volume, post-void residual, median maximum flow rate men refractory du bpo.3 recommendationsstrength ratingcounsel patients evidence detrusor underactivity (du) acontractile detrusor concomitant benign prostatic enlargement potential subjective objective benefits benign prostatic surgery.weakoffer men du benign prostatic obstruction, test phase sacral neuromodulation.weak